NasdaqGS:MDRX

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Allscripts Healthcare Solutions

Executive Summary

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.


Snowflake Analysis

Moderate growth potential and slightly overvalued.


Similar Companies

Share Price & News

How has Allscripts Healthcare Solutions's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MDRX's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

2.7%

MDRX

-3.1%

US Healthcare Services

2.5%

US Market


1 Year Return

-5.0%

MDRX

44.1%

US Healthcare Services

16.3%

US Market

Return vs Industry: MDRX underperformed the US Healthcare Services industry which returned 44.1% over the past year.

Return vs Market: MDRX underperformed the US Market which returned 16.3% over the past year.


Shareholder returns

MDRXIndustryMarket
7 Day2.7%-3.1%2.5%
30 Day43.8%3.4%5.6%
90 Day44.5%27.3%16.4%
1 Year-5.0%-5.0%44.6%44.1%18.8%16.3%
3 Year-27.0%-27.0%112.8%111.5%45.1%35.7%
5 Year-34.3%-34.3%140.9%138.7%75.8%56.8%

Price Volatility Vs. Market

How volatile is Allscripts Healthcare Solutions's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Allscripts Healthcare Solutions undervalued compared to its fair value and its price relative to the market?

13.0%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MDRX ($9.25) is trading below our estimate of fair value ($10.62)

Significantly Below Fair Value: MDRX is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: MDRX is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.

PE vs Market: MDRX is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MDRX's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MDRX is good value based on its PB Ratio (1.2x) compared to the US Healthcare Services industry average (5.9x).


Next Steps

Future Growth

How is Allscripts Healthcare Solutions forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?

63.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MDRX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).

Earnings vs Market: MDRX is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MDRX's is expected to become profitable in the next 3 years.

Revenue vs Market: MDRX's revenue (3% per year) is forecast to grow slower than the US market (9.4% per year).

High Growth Revenue: MDRX's revenue (3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MDRX's Return on Equity is forecast to be low in 3 years time (9.2%).


Next Steps

Past Performance

How has Allscripts Healthcare Solutions performed over the past 5 years?

-27.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MDRX is currently unprofitable.

Growing Profit Margin: MDRX is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: MDRX is unprofitable, and losses have increased over the past 5 years at a rate of 27.2% per year.

Accelerating Growth: Unable to compare MDRX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MDRX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (9.9%).


Return on Equity

High ROE: MDRX has a negative Return on Equity (-4.24%), as it is currently unprofitable.


Next Steps

Financial Health

How is Allscripts Healthcare Solutions's financial position?


Financial Position Analysis

Short Term Liabilities: MDRX's short term assets ($869.8M) do not cover its short term liabilities ($1.1B).

Long Term Liabilities: MDRX's short term assets ($869.8M) exceed its long term liabilities ($834.6M).


Debt to Equity History and Analysis

Debt Level: MDRX's debt to equity ratio (83.4%) is considered high.

Reducing Debt: MDRX's debt to equity ratio has increased from 47.6% to 83.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MDRX has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if MDRX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Allscripts Healthcare Solutions's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MDRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MDRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MDRX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MDRX's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MDRX's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.6yrs

Average management tenure


CEO

Paul Black (62 yo)

7.67yrs

Tenure

US$7,508,613

Compensation

Mr. Paul M. Black has been the Chief Executive Officer of Allscripts Healthcare Solutions, Inc. since December 19, 2012. Mr. Black serves as an Adjunct Professor of Businss at the University of Missouri – ...


CEO Compensation Analysis

Compensation vs Market: Paul's total compensation ($USD7.51M) is above average for companies of similar size in the US market ($USD4.53M).

Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Paul Black
CEO & Director7.67yrsUS$7.51m0.78%
$ 11.7m
Richard Poulton
President & CFO4.83yrsUS$6.13m0.13%
$ 2.0m
Lisa Khorey
Executive VP & Chief Client Delivery Officer3.75yrsUS$3.14m0.056%
$ 836.6k
Joseph Rostock
Senior VP of Development & CTO0.42yrno datano data
Brennan Sullivan
VP & Chief Information Officer0.58yrno datano data
Stephen Shulstein
Vice President of Investor Relations2.17yrsno datano data
Tejal Vakharia
Senior VP & General Counsel0.17yrno data0.12%
$ 1.8m
Richard Elmore
Senior Vice President of Corporate Development & Strategy1.58yrsno datano data
Leah Jones
Senior Vice President of Sales Operations1.58yrsno datano data
Rebecca Whaley
Vice President of Marketing0.42yrno datano data
Erikka Buracchio
Senior Vice President of Human Resources0.17yrno datano data
Paul Lewis
Senior Vice President of Sales & Services and Acting General Manager13.58yrsno datano data

1.6yrs

Average Tenure

56yo

Average Age

Experienced Management: MDRX's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Paul Black
CEO & Director7.67yrsUS$7.51m0.78%
$ 11.7m
David Stevens
Independent Director8.58yrsUS$311.50k0.074%
$ 1.1m
Jonathan Judge
Independent Director4.25yrsUS$314.00k0.035%
$ 531.2k
Michael Klayko
Independent Chairman of the Board6.42yrsUS$389.00k0.072%
$ 1.1m
David Stevens
Independent Director4.25yrsUS$292.53k0.029%
$ 442.4k
Mara Aspinall
Independent Director3.25yrsUS$287.50k0.021%
$ 311.3k
P. Garrison
Independent Director5.08yrsUS$317.50k0.039%
$ 581.7k
Elizabeth Altman
Director0.17yrno datano data

4.7yrs

Average Tenure

63.5yo

Average Age

Experienced Board: MDRX's board of directors are considered experienced (4.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Allscripts Healthcare Solutions, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Allscripts Healthcare Solutions, Inc.
  • Ticker: MDRX
  • Exchange: NasdaqGS
  • Founded: 1986
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$1.507b
  • Shares outstanding: 162.97m
  • Website: https://www.allscripts.com

Number of Employees


Location

  • Allscripts Healthcare Solutions, Inc.
  • 222 Merchandise Mart Plaza
  • Suite 2024
  • Chicago
  • Illinois
  • 60654
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MDRXNasdaqGS (Nasdaq Global Select)YesCommon SharesUSUSDMar 2006
AL21DB (Deutsche Boerse AG)YesCommon SharesDEEURMar 2006

Biography

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health recor ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/08/08 23:47
End of Day Share Price2020/08/07 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.